Form 4 for TWST Twist Bioscience Corp
Accepted 2021-08-20 00:00:00 ET · period of report 2021-08-18 · accession 0001214659-21-008867 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-20 | 2021-08-18 | TWST | Weiss Patrick | COO | S - Sale+OE | $97.11 | -4,905 | 50.5K | -9% | -$476.3K |
| DM | 2021-08-20 | 2021-08-18 | TWST | Weiss Patrick | COO | M - OptEx | $18.73 | +4,905 | 55.4K | +10% | +$91.9K |
| DM | 2021-08-20 | 2021-08-18 | TWST | Weiss Patrick | COO | M - OptEx | $0.00 | -4,905 | 4,209 | -54% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-18 | S | D | 4,905 | $97.11 | 50,460 | D | — | — | |
| 2 | Common | Common Stock | 2021-08-18 | M | A | 1,974 | $26.66 | 54,538 | D | — | — | |
| 3 | Common | Common Stock | 2021-08-18 | M | A | 2,104 | $8.82 | 52,564 | D | — | — | |
| 4 | Common | Common Stock | 2021-08-18 | M | A | 827 | $25.02 | 55,365 | D | — | — | |
| 5 | Derivative | Employee Stock Option (right to buy) | 2021-08-18 | M | D | 827 | $0.00 | 23,167 | D | $25.02 · — to 2029-12-09 | 827 Common Stock | (F4) 25% of the shares subject to the option vested and became exercisable on October 24, 2020 and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. |
| 6 | Derivative | Employee Stock Option (right to buy) | 2021-08-18 | M | D | 1,974 | $0.00 | 55,272 | D | $26.66 · — to 2028-11-18 | 1,974 Common Stock | (F3) 20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. |
| 7 | Derivative | Employee Stock Option (right to buy) | 2021-08-18 | M | D | 2,104 | $0.00 | 4,209 | D | $8.82 · — to 2027-09-28 | 2,104 Common Stock | (F2) The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. |